BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1859424)

  • 21. Induction of apoptosis by bufalin in human tumor cells is associated with a change of intracellular concentration of Na+ ions.
    Kawazoe N; Aiuchi T; Masuda Y; Nakajo S; Nakaya K
    J Biochem; 1999 Aug; 126(2):278-86. PubMed ID: 10423518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ITR‑284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
    Yang JS; Lee CY; Cho HC; Lu CC; Kuo SC; Wen YF; Tsai FJ; Lee MR; Tsai SC
    Oncol Rep; 2018 Jan; 39(1):383-391. PubMed ID: 29138846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
    Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
    Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.
    Hassan HT; Grell S; Borrmann-Danso U; Freund M
    J Interferon Cytokine Res; 1996 Feb; 16(2):139-46. PubMed ID: 8742366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin.
    Chou S; Kaneko M; Nakaya K; Nakamura Y
    Biochem Biophys Res Commun; 1990 Jan; 166(1):160-7. PubMed ID: 2302199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in differentiation and apoptosis induced by bufalin in cJun overexpressing U-937 cells.
    Szabo E; Francis J; Birrer MJ
    Int J Oncol; 1998 Feb; 12(2):403-9. PubMed ID: 9458368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells.
    Kawazoe N; Watabe M; Masuda Y; Nakajo S; Nakaya K
    Oncogene; 1999 Apr; 18(15):2413-21. PubMed ID: 10229192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pilot study on the mechanisms of growth inhibitory effect of cinobufagin on HeLa cells].
    Wang L; Wu J; Li M; Yang XW; Cui JR
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):717-20. PubMed ID: 16483480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression.
    Zhu Z; Li E; Liu Y; Gao Y; Sun H; Wang Y; Wang Z; Liu X; Wang Q; Liu Y
    Acta Haematol; 2012; 128(3):144-50. PubMed ID: 22890165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan.
    Datta P; Dasgupta A
    Ther Drug Monit; 2000 Apr; 22(2):155-9. PubMed ID: 10774625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells.
    Watabe M; Kawazoe N; Masuda Y; Nakajo S; Nakaya K
    Cancer Res; 1997 Aug; 57(15):3097-100. PubMed ID: 9242431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of bufalin and cinobufotalin, two bufadienolides respectively more active and less active than ouabain, on ouabain binding and 86Rb uptake by human erythrocytes.
    Brownlee AA; Johnson P; Mills IH
    Clin Sci (Lond); 1990 Feb; 78(2):169-74. PubMed ID: 2155744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells.
    Watabe M; Ito K; Masuda Y; Nakajo S; Nakaya K
    Oncogene; 1998 Feb; 16(6):779-87. PubMed ID: 9488042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Biological Evaluation of Novel Bufalin Derivatives.
    Sampath V; Horesh N; Sasi B; Zannadeh H; Pogodin I; Singh SV; Deutsch J; Lichtstein D
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The mechanisms of inhibitory effect of bufalin on human leukemia cells].
    Xu R; Chen X; Chen L; Qian J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):359-61. PubMed ID: 11877005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells.
    Yang C; Cai H; Meng X
    Int Immunopharmacol; 2016 Jul; 36():17-22. PubMed ID: 27104314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.